Advanced Search
LI Jingping, ZHANG Xiangmei, ZHENG Lihua, LIU Yunjiang. Progress on FOXP3 Expression in Breast Cancer cells[J]. Cancer Research on Prevention and Treatment, 2016, 43(12): 1076-1080. DOI: 10.3971/j.issn.1000-8578.2016.12.014
Citation: LI Jingping, ZHANG Xiangmei, ZHENG Lihua, LIU Yunjiang. Progress on FOXP3 Expression in Breast Cancer cells[J]. Cancer Research on Prevention and Treatment, 2016, 43(12): 1076-1080. DOI: 10.3971/j.issn.1000-8578.2016.12.014

Progress on FOXP3 Expression in Breast Cancer cells

  • Forkhead Box Protein 3 (FOXP3) is a transcription factor critically involved in the development and functions of immunosuppressive CD4+CD25+ regulatory T cell (Treg). FOXP3 expression was thought to be restricted to Treg, however, recent studies have provided clear evidence that various types of human tumor cells expressed FOXP3, including breast caner. But the subcellular localization and the extent to which FOXP3 is expressed in human breast cancer epithelial cells are conflicting. Many preclinical studies have demonstrated that FOXP3 acts as an X-linked tumor suppressor gene in the pathogenesis of breast cancer, while, more clinical studies reported unfavorable prognosis of tumors with FOXP3 expression. Despite increasing knowledge about the biology of FOXP3 in breast cancer cells, the biological functions and significance of FOXP3 expression in breast cancer remain still controversial and not clearly defined. Here, the present review discusses the role of FOXP3 in breast cancer aiming at new strategies for breast cancer prognosis.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return